Skip to main content
PMC home page
Journal of Assisted Reproduction and Genetics logoLink to Journal of Assisted Reproduction and Genetics
. 2001 Feb;18(2):91–96. doi: 10.1023/A:1026582608645

CLINICAL ASSISTED REPRODUCTION: Determination of the Efficiency of Controlled Ovarian Hyperstimulation in the Gonadotropin-Releasing Hormone Agonist-Suppression Cycle Using the Initial Follicle Count During Gonadotropin Stimulation

Fu-Jen Huang 1, Shiuh-Young Chang 1, Meng-Yin Tsai, Fu-Tsai Kung, Jick-Fuu Wu, Hsueh-Wen Chang 2
PMCID: PMC3455557  PMID: 11285987

Abstract

Purpose: Our purpose was to evaluate the relationship between the initial follicle count during gonadotropin stimulation after gonadotropin-releasing hormone (GnRH) agonist suppression and the efficiency of controlled ovarian hyperstimulation (COH) in patients receiving treatment with assisted reproductive technologies (ARTs).

Methods: A total of 338 COH procedures in 291 couples was performed with cycles that reached the stage of oocyte retrieval. The ovarian antral follicle number was measured using transvaginal ultrasonography at the folliculometry during gonadotropin stimulation by GnRH agonist suppression in patients undergoing ARTs. Controlled ovarian hyperstimulation was accomplished using GnRH agonist down-regulation combined with FSH and menotropin stimulation. The characteristics of oocytes after retrieval and embryos after in vitro culture and the pregnancy rates were assessed.

Results: The procedures performed included 195 ET cycles, 129 TET cycles, and 14 incomplete cycles. The treatment cycles were divided into four categories according to the antral follicle number (i.e., ≤5, 6–10, 11–15, and ≥16) at the first folliculometry to evaluate the influence of various factors. The antral follicle count correlated significantly with the patient age, dosage of gonadotropins, serum estradiol concentration, number of antral follicles (≥13 mm) while receiving hCG injections, number of oocytes retrieved, and, later, number of embryos transferred. There was a trend toward an increasing number of pregnancies per cycle as the number of antral follicles increased (14.7, 26.5, 44, and 45%, respectively).

Conclusions: We were able to predict the efficiency of COH and outcome of ARTs based on the follicle count during the first folliculometry during gonadotropin stimulation after GnRH agonist suppression. The results of the folliculometry significantly predicted the ovarian response to COH and the outcome of ARTs in the current treatment cycle.

Keywords: Controlled ovarian hyperstimulation, gonadotropin-releasing hormone agonist suppression, initial follicle count, gonadotropin stimulation, folliculometry

Full Text

The Full Text of this article is available as a PDF (66.8 KB).

REFERENCES

  • 1.Scott RT, Jr, Hofmann GE. Prognostic assessment of ovarian reserve. Fertil Steril. 1995;63:1–11. [PubMed] [Google Scholar]
  • 2.Wallach EE. Pitfalls in evaluating ovarian reserve. Fertil Steril. 1995;63:12–14. doi: 10.1016/s0015-0282(16)57288-4. [DOI] [PubMed] [Google Scholar]
  • 3.Gosden RG. Maternal age: A major factor affecting the prospects and outcome of pregnancy. Ann NY Acad Sci. 1985;442:45–57. doi: 10.1111/j.1749-6632.1985.tb37504.x. [DOI] [PubMed] [Google Scholar]
  • 4.Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril. 1989;51:651–654. doi: 10.1016/s0015-0282(16)60615-5. [DOI] [PubMed] [Google Scholar]
  • 5.Toner JP, Philput CB, Jones GS, Muasher SJ. Basal folliclestimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril. 1991;55:784–791. doi: 10.1016/s0015-0282(16)54249-6. [DOI] [PubMed] [Google Scholar]
  • 6.Hansen LM, Batzer FR, Gutmann JN, Corson SL, Kelly MP, Gocial B. Evaluating ovarian reserve: Follicle stimulating hormone and oestradiol variability during cycle days 2-5. Hum Reprod. 1996;11:486–489. doi: 10.1093/humrep/11.3.486. [DOI] [PubMed] [Google Scholar]
  • 7.Licciardi FL, Liu H-C, Rosenwaks Z. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril. 1995;64:991–994. doi: 10.1016/s0015-0282(16)57916-3. [DOI] [PubMed] [Google Scholar]
  • 8.Smotrich DB, Widra EA, Gindoff PR, Levy MJ, Hall JL, Stillman RJ. Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil Steril. 1995;64:1136–1140. [PubMed] [Google Scholar]
  • 9.Loumaye E, Billion J-M, Mine J-M, Psalti 1, Pensis M, Thomas K. Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test. Fertil Steril. 1990;53:295–301. doi: 10.1016/s0015-0282(16)53284-1. [DOI] [PubMed] [Google Scholar]
  • 10.Tanbo T, Dale PO, Lunde O, Norma N, Abyholm T. Prediction of response to controlled ovarian hyperstimulation: A comparison of basal and clomiphene citrate-stimulated folliclestimulating hormone levels. Fertil Steril. 1992;57:819–824. doi: 10.1016/s0015-0282(16)54965-6. [DOI] [PubMed] [Google Scholar]
  • 11.Winslow KL, Toner JP, Brzyski RG, Oehninger SC, Acosta AA, Muasher SJ. The gonadotropin-releasing hormone agonist stimulation test: A sensitive predictor of performance in the flare-up in vitro fertilization cycle. Fertil Steril. 1991;56:711–717. doi: 10.1016/s0015-0282(16)54604-4. [DOI] [PubMed] [Google Scholar]
  • 12.Fanchin R, de Ziegler D, Olivennes F, Taieb J, Dzik A, Frydman R. Exogenous follicle stimulating ovarian reserve test (EFORT): A simple and reliable screening test for detecting ‘poor responders’ in in-vitro fertilization. Hum Reprod. 1994;9:1607–1611. doi: 10.1093/oxfordjournals.humrep.a138760. [DOI] [PubMed] [Google Scholar]
  • 13.Chang SY, Lee CL, Wang ML, Hu ML, Lai YM, Chang MY, Soong YK. No detrimental effect in delaying initiation of gonadotropin administration after pituitary desensitization with GnRH-a. Fertil Steril. 1993;59:183–186. doi: 10.1016/s0015-0282(16)55636-2. [DOI] [PubMed] [Google Scholar]
  • 14.WHO Laboratory Manual for Examination Semen and Sperm-Cervical Mucus Interaction. 3rd ed. Cambridge: Cambridge University Press; 1992. [Google Scholar]
  • 15.Kruger TF, Menkveld R, Stander FS, Lombard CJ, Van der Merwe JP, Van Zyl JA, Smith K. Sperm morphologic features as a prognostic factor in in vitro fertilization. Fertil Steril. 1986;46:1118–1123. doi: 10.1016/s0015-0282(16)49891-2. [DOI] [PubMed] [Google Scholar]
  • 16.Huang FJ, Chang SY, Tsai MY, Lin YC, Kung FT, Lin YC, Wu JF, Lu YJ. Relationship of the human cumulus-free oocyte maturational profile with in vitro outcome parameters after intracytoplasmic sperm injection. J Assist Reprod Genet. 1999;16(9):209–211. doi: 10.1023/A:1020551000150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Tsai MY, Huang FJ, Kung FT, Lin YC, Chang SY, Wu JF, Chang HW. The influence of polyvinylpyrrolidone on the outcome of intracytoplasmic sperm injection. J Reprod Med. 2000;45(2):115–120. [PubMed] [Google Scholar]
  • 18.Toth TL, Hodgen GD. Ovarian follicular growth and maturation. In: Wallach EE, Zacury HA, editors. Reproductive Medicine and Surgery. St. Louis: CV Mosby; 1995. pp. 137–157. [Google Scholar]
  • 19.McNatty K. Ovarian follicular development from the onset of luteal regression in human and sheep. In: Rolland R, van Hall EV, Hillier SG, McNatty KP, Schoemaker J, editors. Follicular Maturation and Ovulation. Amsterdam: Excerpta Medica; 1982. pp. 1–18. [Google Scholar]
  • 20.Goodman AL, Hodgen GD. The ovarian triad of the primate menstrual cycle. Recent Prog Horm Res. 1983;39:1. doi: 10.1016/b978-0-12-571139-5.50005-7. [DOI] [PubMed] [Google Scholar]
  • 21.Kerin J, Edmonds D, Warnes G, et al. Morphological and functional relations of Graafian follicle growth to ovulation in women using ultrasonic, laparoscopic, and biochemical measurements. Br J Obstet Gynaecol. 1981;88:81–90. doi: 10.1111/j.1471-0528.1981.tb00947.x. [DOI] [PubMed] [Google Scholar]
  • 22.Brown JB. Pituitary control of ovarian function: Concepts derived from gonadotropin therapy. Aust NZ J Obstet Gynaecol. 1978;18:46–54. doi: 10.1111/j.1479-828x.1978.tb00011.x. [DOI] [PubMed] [Google Scholar]
  • 23.Schoemaker J, van Weissenbruch MM, Scheele F, van der Meer M. The FSH threshold concept in clinical ovulation induction. Balliere Clin Obstet Gynecol. 1993;7:297–308. doi: 10.1016/s0950-3552(05)80132-4. [DOI] [PubMed] [Google Scholar]
  • 24.Lolis DE, Tsolas O, Messinis IE. The follicle-stimulating hormone threshold level for follicle maturation in superovulated cycles. Fertil Steril. 1995;63:1272–1277. doi: 10.1016/s0015-0282(16)57610-9. [DOI] [PubMed] [Google Scholar]
  • 25.Schipper I, Hop WCJ, Fauser BCJM. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: Duration, rather than magnitude, of FSH increase affects follicle development. J Clin Endocrinol Metab. 1998;83:1292–1298. doi: 10.1210/jcem.83.4.4710. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Assisted Reproduction and Genetics are provided here courtesy of Springer Science+Business Media, LLC

RESOURCES